NORPACE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norpace, and when can generic versions of Norpace launch?
Norpace is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in NORPACE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norpace
A generic version of NORPACE was approved as disopyramide phosphate by TEVA on February 22nd, 1985.
Summary for NORPACE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Clinical Trials: | 1 |
Patent Applications: | 1,138 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for NORPACE |
What excipients (inactive ingredients) are in NORPACE? | NORPACE excipients list |
DailyMed Link: | NORPACE at DailyMed |
Recent Clinical Trials for NORPACE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 3 |
Medtronic | Phase 3 |
Pharmacology for NORPACE
Drug Class | Antiarrhythmic |
Anatomical Therapeutic Chemical (ATC) Classes for NORPACE
US Patents and Regulatory Information for NORPACE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | NORPACE | disopyramide phosphate | CAPSULE;ORAL | 017447-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer | NORPACE CR | disopyramide phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 018655-002 | Jul 20, 1982 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | NORPACE | disopyramide phosphate | CAPSULE;ORAL | 017447-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |